TAVR

Post-dilatación de válvulas autoexpandibles

Balloon expandable vs Self-Expanding Valves: The Best Option for ViV-TAVR in Small Annuli

TAVR has consolidated as an increasingly valid alternative to treat failed surgical aortic valve bioprostheses. &nbsp; One of the major challenges it presents is patients with small annuli treated with a surgical bioprosthesis.&nbsp; There is little data available about this scenario. A few observational studies have shown what appears to be a hemodynamic advantage of<a href="https://solaci.org/en/2022/08/23/balloon-expandable-vs-self-expanding-valves-the-best-option-for-viv-tavr-in-small-annuli/" title="Read more" >...</a>

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen oval

Combination of Percutaneous Suture Devices after TAVR to Reduce Vascular Complications

Current use of transcatheter aortic valve replacement (TAVR) has increased in intermediate-risk patients and has even been used in low-risk patients. Vascular access-related complications and bleeding are still frequent after transfemoral TAVR, being associated with poor short- and long-term outcomes. Using percutaneous closure devices has allowed operators to close the access site without surgery. The<a href="https://solaci.org/en/2022/08/16/combination-of-percutaneous-suture-devices-after-tavr-to-reduce-vascular-complications/" title="Read more" >...</a>

tavi vs cirugia partner i

Non-Cardiac Surgery After TAVR Is Safe

There are increasingly more patients who have undergone transcatheter aortic valve replacement (TAVR) and require a non-cardiac intervention, or patients with other diseases who need surgery and are diagnosed with aortic stenosis.&nbsp; In addition, on many occasions, surgery must be performed as soon as possible (as in cases of cancer) or is an emergency procedure.<a href="https://solaci.org/en/2022/08/11/non-cardiac-surgery-after-tavr-is-safe/" title="Read more" >...</a>

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR

On the last session from day 1 of SOLACI-SOCIME 2022 on structural pathology, Dr. Raj Makkar, an international expert on the subject, talked about transcatheter aortic valve replacement (TAVR) in pure aortic regurgitation (AR), which presents several implantation challenges, such as insufficient anchoring, embolization, residual regurgitation, ring rupture, etc.&nbsp; As opposed to patients with aortic<a href="https://solaci.org/en/2022/08/09/the-best-of-the-solaci-socime-2022-main-arena-structural-selected-topics-of-tavr/" title="Read more" >...</a>

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the Main Arena at SOLACI-SOCIME 2022: TAVR Complex Anatomy

In the transcatheter aortic valve replacement (TAVR) session we had a presentation by Dr. John P. Vavalle (USA), head of the Structural Heart Disease Program at the University of North Carolina at Chapel Hill.&nbsp; In his presentation, he showed how far the limits of percutaneous aortic valve implantation can be stretched by briefly showing successful<a href="https://solaci.org/en/2022/08/09/the-best-of-the-main-arena-at-solaci-socime-2022-tavr-complex-anatomy/" title="Read more" >...</a>

El Grupo MIL realizó 4 TAVIS en Paraguay

The Latin American Group of Interventionist Women Performed 4 TAVR Cases in Paraguay

The MIL-SOLACI continues to grow and keeps developing activities to foster integration and women’s participation all across Latin America.&nbsp; IN this opportunity, and for the first time, the area directed by Dr. Carla Agatiello (ARG) performed 4 transcatheter aortic valve implantations (TAVR) at the National University’s Clinical Hospital of Asunción, in Paraguay.&nbsp; The interventions, performed<a href="https://solaci.org/en/2022/06/30/the-latin-american-group-of-interventionist-women-performed-3-tavr-cases-in-paraguay/" title="Read more" >...</a>

La enfermedad vascular periférica se asocia a más eventos en el TAVI

TAVR, More Information Supports Its Use

TAVR has been reported beneficial in the treatment of high and intermediate risk patients but, initially, randomized clinical trials have shown vascular complication and pacemaker implantation rates higher than SAVR in low-risk patients. This will most certainly improve as operator experience and device development advance. This is a randomized 1:1 study including 458 patients receiving<a href="https://solaci.org/en/2022/06/09/tavr-more-information-supports-its-use/" title="Read more" >...</a>

acceso_transcaval

TAVR: If Not Transfemoral, We Should Consider Transcaval Access

Transcatheter aortic valve replacement (TAVR) through transfemoral access has already proven its great benefits, but this access cannot be used in certain patients, and alternative accesses need to be considered for such cases. One of the most commonly used accesses is the transaxillary or transubclavian access (AX), which, however, is associated with more complications (especially<a href="https://solaci.org/en/2022/06/01/tavr-if-not-transfemoral-we-should-consider-transcaval-access/" title="Read more" >...</a>

EuroPCR 2022 | Cambios en el daño cardíaco luego del reemplazo valvular aórtico por cirugía

EuroPCR 2022 | Should Revascularization Be Performed Before TAVR in Patients with Stable Coronary Disease?

Currently, the American and European guidelines recommend coronary angioplasty in patients with severe aortic stenosis with lesions &gt;70% (Class IIa) who will undergo transcatheter aortic valve replacement (TAVR). However, the benefit of performing a revascularization in these patients is still uncertain. This prospective multicenter study included 2025 patients divided into two groups: complete revascularization (N&nbsp;=&nbsp;1310)<a href="https://solaci.org/en/2022/05/24/europcr-2022-should-revascularization-be-performed-before-tavr-in-patients-with-stable-coronary-disease/" title="Read more" >...</a>

Top